Protagonist Therapeutics Inc. (PTGX) rose 6.35% or 0.45 to $7.54. It is about 87067 shares traded, which is 30.54% compare to the average total volume 285059. The market cap of PTGX is $159.88 million. The year to date change is -60.13%. The 52 week price range is from $5.5 to $23.97. Price of PTGX have changed 3.96% during last week. It have changed -1.66% over last month, -19.43% over last 3 months, -64.25% over last 6 months and -42.73% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 7.20. It is -4.51% below current price. The 200-day Moving Averages for PTGX is 14.60. It is 93.63% above current price. The 52-week High is 23.97. It is 217.90% from the current price. The 52-week Low is 5.5. It is -27.06% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of PTGX is 1.63 on 2018-06-15. Short % to float is 2.05%. There are some statistics of PTGX. It is has market cap $159.88 million. The share outstanding is 21.20 million. The average volume is 285059. The revenue is 8.78M. The percent of top 15 Institution holding is 63.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -32.21%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -26.32%.